International Patent: CONCOMITANT ADMINISTRATION OF SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR RELACORILANT AND P-GLYCOPROTEIN SUBSTRATES

GENEVA, Oct. 9 -- CORCEPT THERAPEUTICS INCORPORATED filed a patent application (US2025/034547) for “CONCOMITANT ADMINISTRATION OF SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR RELACORILANT AND P-GLYCOPROTEIN SUBSTRATES”. With publication no. WO/2025/265030, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61K 31/4745

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....